@misc{indiciae0226e619600f,
  title = {Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.},
  author = {M Karthaus and Harald Ballo and Wolgang Abenhardt and Tilmann Steinmetz and Thomas Geer and Jorg Schimke and Dietrich Braumann and Rudiger Behrens and Dirk Behringer and Manfred Kindler and Helmut Messmann and Hans-Peter Boeck and Roland Greinwald and Ulrich Kleeberg},
  year = {2005},
  doi = {10.1159/000086971},
  url = {https://pubmed.ncbi.nlm.nih.gov/16020959/},
  note = {Source identifier: 16020959}
}